---
figid: PMC10815772__ijms-25-00849-g002
figtitle: Molecular Targeting of the Fibroblast Growth Factor Receptor Pathway across
  Various Cancers
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10815772
filename: PMC10815772__ijms-25-00849-g002.jpg
figlink: /pmc/articles/PMC10815772/figure/F2
number: F2
caption: Types of FGFR pathway inhibitors
papertitle: Molecular Targeting of the Fibroblast Growth Factor Receptor Pathway across
  Various Cancers
reftext: Khine S. Shan, et al. Int J Mol Sci. 2024 Jan;25(2).
year: '2024'
doi: 10.3390/ijms25020849
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: FGF | FGFR | fibroblast growth factor receptor | fibroblast growth factor
  | targeted therapy | genomic profiling | personalized medicine
automl_pathway: 0.9640765
figid_alias: PMC10815772__F2
figtype: Figure
redirect_from: /figures/PMC10815772__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10815772__ijms-25-00849-g002.html
  '@type': Dataset
  description: Types of FGFR pathway inhibitors
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FGFR3
  - FGF1
  - FGF2
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FGF10
  - FGF11
  - FGF12
  - FGF13
  - FGF14
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGFR1
  - FGFR2
  - FGFR4
  - FGFRL1
  - PDGFRB
  - PDGFRA
  - KDR
  - FLT1
  - FLT4
  - KIT
  - RET
  - TRAP
  - ACP5
  - CD40LG
  - TRAF2
  - TRRAP
  - TDRD7
  - SCYL1
  - PTPN11
  - FRS2
  - GRB2
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - PLCG1
  - PLCG2
  - XYLT2
  - SOS1
  - SOS2
  - KRAS
  - HRAS
  - NRAS
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - AKT1
  - AKT2
  - AKT3
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - MTOR
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - inhibitors
  - Lenvatinib
  - Pazopanib
  - Ponatinib
  - MEK
---
